The 12 closest competitors and alternatives to OrganOx among medical devices companies — ranked by similarity to what OrganOx actually does, not by market-cap band.
Subscribe to see OrganOx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
OrganOx is an organ technology company founded as a spin-out from the University of Oxford, United Kingdom. It pioneers liver perfusion technology to address transplant challenges and improve transplant success through innovation and clinical research.
OrganOx is a medical devices company headquartered in United Kingdom. Xcout tracks 19 named people at OrganOx, including Naoya Iwata (Chief Executive Officer & President). Xcout recorded 33 job postings from OrganOx in the last 90 days.
13 more named people on record for OrganOx, with roles, board committees and tenure — see the full roster →
Xcout recorded 33 job postings from OrganOx in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see OrganOx's hiring signals →
Ranked by semantic similarity — how close each company is to OrganOx by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Orthox is a medical device company founded to transform how injuries to cartilage and other hard-to-heal human tissues are treated, with its headquarters located in Oxfordshire, United Kingdom.
Similar medical devices company
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
Similar medical devices company
Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothenburg, Sweden, the company extends its operations across Sweden, the United States, the broader regions of North and South America, Europe, the Middle East, Africa, and the Asia Pacific. Their product line encompasses the XVIVO System (XPS), an integrated, off-the-shelf cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). Accompanying this is the XPS Disposable Lung Kit, supplying necessary sterile disposables and pre-packaged components. They also provide STEEN Solution, a uniquely formulated buffered extracellular solution optimized for perfusing isolated donor lungs during EVLP, and Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte solution for organ preservation. Additional offerings include the XVIVO Silicone Tubing Set for efficient flushing of donor lungs during procurement, as well as the XVIVO LS and XVIVO Disposable Lung Set, which together constitute a dedicated EVLP device. Furthermore, Xvivo Perfusion supplies the XVIVO Organ Chamber, a single-use sterile disposable container designed as a temporary holding unit for isolated lungs before transplantation, alongside the single-use, sterile XVIVO Lung Cannula Set.
Similar medical devices company
Bridge to Life Ltd. provides organ preservation solutions and proven medical technologies. Headquartered in Duluth, Georgia, the privately held company also maintains European operations.
Similar medical devices company
Glycorex Transplantation AB develops medical devices that utilize proprietary technology to selectively remove specific antibodies from the blood. Its core product, Glycosorb® ABO, enables blood group incompatible organ, stem cell, and heart transplants. Additionally, the company is expanding its applications to include universal blood plasma production and treatments for autoimmune diseases such as rheumatoid arthritis.
Similar medical devices company
ALung Technologies, Inc. is a leading provider of low-flow extracorporeal carbon dioxide removal technologies. The company was acquired by LivaNova in May 2022. It focuses on advancing respiratory care solutions.
Similar medical devices company
Xeltis is a medical technology company that develops bioresorbable cardiovascular implants, such as artificial blood vessels and valves. Utilizing its proprietary Restorex technology, the company's products are designed to be gradually replaced by the patient's own living tissue to treat life-threatening conditions and improve vascular surgery outcomes.
Similar medical devices company
Sequana Medical is a medical technology company that develops treatments for fluid overload associated with liver disease, heart failure, and cancer. Its primary product is the alfapump system, an implantable medical device designed to automatically remove fluid from the abdominal cavity for patients with recurrent or refractory ascites due to liver cirrhosis.
Medical Equipment Manufacturing
Origin Sciences is a medical technology company based in the UK that develops innovative devices and tests to aid in the detection and diagnosis of gastrointestinal diseases.
Similar medical devices company
VQ Biomedical develops a minimally-invasive intravascular oxygenation catheter designed to deliver supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure. The technology provides gas exchange independently of injured lungs to support healing while avoiding the complications of mechanical ventilation or external ECMO pumps. The company serves healthcare providers and critical care patients.
Similar medical devices company
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Medical Device
ALung Technologies develops extracorporeal respiratory support devices, including the Hemolung Respiratory Assist System, designed to remove carbon dioxide from blood and support patients with acute respiratory failure. Its products are intended for hospitals and critical-care clinicians treating patients who need respiratory support, including certain patients with severe COPD or who may otherwise require mechanical ventilation.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for OrganOxand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →